Beyond the Label: Ensuring That Drug Benefits Outweigh Risks in the Food and Drug Administration's Risk Evaluation and Mitigation Strategy Program. [electronic resource]
Producer: 20200302Description: 1017-1019 p. digitalISSN:- 1572-0241
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.